Inactive Instrument

TOTL BRAI

Equities

TTB

AU0000032435

Total Brain : Dr. Evian Gordon, Chief Medical Officer, Total Brain, to Address the Role of Collaborative Care in Treating Depression at The Healthcare Innovation Congress

May 20, 2022 at 04:05 pm EDT

Panel discussion slated for Tuesday, May 24 at 11:25 a.m.

SAN FRANCISCO, May 20, 2022 - Total Brain today announced that the company's executive chairman and chief medical officer, Evian Gordon, MD, PhD, will moderate a panel discussion on The Role of Collaborative Care in Treating Depression at The Healthcare Innovation Congress on Tuesday, May 24, 11:25 a.m. to 12:10 p.m. Dr. Gordon will be joined by Kerna Health's Founder and CEO Andreas Typaldos and Chief Revenue Officer Crystal Lore.

"The silos within and between physical and mental health are finally being inter-connected by collaborative care," said Dr. Gordon. "It is inspiring to provide applied integrative neuroscience assessments and treatment support into a leading-edge collaborative care company. And timely to jointly help to bridge gaps in treatment, improve patient outcomes and reduce healthcare costs."

During this session on value-based outcomes in depression, Dr. Gordon and panelists will focus on evidence-based outcomes from integrating behavioral healthcare and primary healthcare within a primary care setting and explore recent case studies on how Kerna Health is integrating collaborative care across its patient and provider network.

To claim a complimentary guest pass visit thINc 360 and use promo code TB2022 when you register.

About Total Brain Limited (ASX: TTB)

Total Brain Limited is a San Francisco and Sydney-based applied, integrative neuroscience company that has developed and offers Total Brain, a SaaS-based mental health platform powered by the world's largest standardized brain database.

Its SaaS platform has helped more than one million registered users to-date scientifically measure and optimize their brain capacities while managing the risk of common mental conditions. Benefits for providers include improved patient outcomes, tracking of evidence-based outcomes across the continuum of care, and a reduction in clinician fatigue. Benefits for employers and payers include better mental healthcare access, lower costs, and higher productivity. For more information, please visit www.totalbrain.com and follow on Twitter, LinkedIn, and Facebook.

Latest news about TOTL BRAI

Transcript : Total Brain Limited - Shareholder/Analyst Call	23-03-09
Total Brain Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-28	CI
Total Brain to Delist on Australian Bourse on March 1	23-02-14	MT
Transcript : Total Brain Limited - Shareholder/Analyst Call	23-01-31
David Daglio Steps Down from Board of Directors of Total Brain Limited	22-12-05	CI
Total Brain Completes Business Asset Sale to SonderMind; Shares Up 5%	22-10-31	MT
SonderMind Inc. acquired Assets of Total Brain Limited.	22-10-31	CI
Transcript : Total Brain Limited - Shareholder/Analyst Call	22-10-30
Total Brain Limited Auditor Raises 'Going Concern' Doubt	22-09-29	CI
Total Brain Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-30	CI
Total Brain Agrees to Salell Business for $10 Million	22-08-05	MT
SonderMind Inc. entered into an agreement to acquire Assets of Total Brain Limited for $10 million.	22-08-04	CI
Total Brain Limited announced that it expects to receive AUD 0.0396 million in funding	22-06-01	CI
VeriSIM Life and Total Brain Announce Strategic Collaboration Agreement Applying AI to Develop New Drugs for Neurological Disorders	22-05-26	CI
Total Brain Limited Announces 5-Year Extension of AARP Contract	22-05-10	CI
Transcript : Total Brain Limited, Q3 2022 Earnings Call, May 04, 2022	22-05-03
Total Brain Limited announced that it expects to receive AUD 1.278485 million in funding	22-04-04	CI
Total Brain Limited Provides Varga Capital Loan Update	22-03-29	CI
Total Brain Limited Announces Repayment of F45 Loan	22-03-21	CI
Total Brain Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-27	CI
Transcript : Total Brain Limited, Q2 2022 Earnings Call, Feb 03, 2022	22-02-02
Kerna Health Signs Deal with Total Brain Limited to Integrate Total Brain Platform into Existing Behavioral Health Technologies	22-01-13	CI
Australian Shares Hit Nearly Four-Month High Despite Record COVID-19 Cases	21-12-29	MT
Total Brain Surges 18% Following Licensing Deal With Alto Neuroscience	21-12-28	MT
Total Brain Limited Enters into Data Licensing Deal with Alto Neuroscience	21-12-28	CI

Chart TOTL BRAI

Duration

Period

More charts

Company Profile

Total Brain Limited is an Australia-based company focused on developing and selling brain health products. It is engaged in the development and commercialization of brain health products, primarily delivered to a range of users through Total Brain platform. The Company's Total Brain platform is a neuroscience-based mental health and brain performance solution that starts with a self-monitoring and self-care app for individuals that drives robust team analytics for companies and ongoing monitoring for providers. The Company's Total Brain app allows individuals to self-monitor brain capacities, screen for mental health risks, and improve overall mental health and brain performance with self-care exercises to improve overall brain capacity and mental health. The Total Brain app functions include self-monitoring brain capacities and mental state; screen for risk of common mental conditions; personalized self-care recommendations for improved mental health, and in-the-moment stress relief.

Sector

More about the company